Extremely high anti-Mullerian hormone levels detected during infertility workup revealing sex cord tumor with annular tubules and underlying Peutz-Jeghers syndrome: A case report

被引:3
作者
Cicek, Ozge Senem Yucel [1 ]
Gezer, Sener [2 ]
Cakir, Ozgur [3 ]
Gurbuz, Rumeysa Hekimoglu [4 ]
机构
[1] Kocaeli Univ, Fac Med, Dept Obstet & Gynecol, Assisted Reprod Technol Clin, Kocaeli, Turkey
[2] Kocaeli Univ, Fac Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Kocaeli, Turkey
[3] Kocaeli Univ, Fac Med, Dept Radiol, Izmit, Turkey
[4] Bezmialem Univ, Fac Med, Dept Histol & Embryol, Istanbul, Turkey
关键词
anti-Mullerian hormone; infertility; Peutz-Jeghers syndrome; preimplantation genetic testing; sex cord tumor with annular tubules; OVARIAN; MARKER;
D O I
10.1111/jog.15107
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
We report an infertile, but otherwise asymptomatic woman, whose extremely high anti-Mullerian hormone (AMH) level detected during infertility investigation led to the diagnosis of sex cord tumor with annular tubules (SCTAT) which is a very rare sex cord-stromal tumor (SCST) and eventually revealed a previously undiagnosed hereditary cancer syndrome, Peutz-Jeghers syndrome (PJS). A 33-year-old woman attended Kocaeli University ART Clinic for infertility evaluation. Her AMH level was 319.63 ng/ml. Detection of bilateral ovarian cysts required surgical evaluation. The histopathological examination of ovaries revealed SCTAT. The strong association of SCTAT with PJS raised the suspicion of this syndrome. Whole STK11 gene sequencing confirmed PJS diagnosis. AMH has become a widely used tool in the evaluation of infertile women. Clinicians dealing with infertility should be familiar with the utility of AMH measurement besides being a marker of ovarian reserve. Detection of high AMH concentrations should raise the suspicion of an SCST.
引用
收藏
页码:492 / 496
页数:5
相关论文
共 17 条
  • [1] Ayadi-Kaddour A, 2004, Pathologica, V96, P117
  • [2] The role of anti-Mullerian hormone (AMH) in ovarian disease and infertility
    Bedenk, Jure
    Vrtacnik-Bokal, Eda
    Virant-Klun, Irma
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2020, 37 (01) : 89 - 100
  • [3] Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion
    Daar, Judith
    Benward, Jean
    Collins, Lee
    Davis, Joseph
    Davis, Owen
    Francis, Leslie
    Gates, Elena
    Ginsburg, Elizabeth
    Gitlin, Susan
    Klipstein, Sigal
    McCcullough, Laurence
    Paulson, Richard
    Reindollar, Richard
    Ryan, Ginny
    Sauer, Mark
    Tipton, Sean
    Westphal, Lynn
    Zweifel, Julianne
    [J]. FERTILITY AND STERILITY, 2018, 109 (06) : 989 - 992
  • [4] The clinical utility of serum anti-Mullerian hormone in the follow-up of ovarian adult-type granulosa cell tumorsA comparative study with inhibin B
    Farkkila, Anniina
    Koskela, Sanna
    Bryk, Saara
    Alfthan, Henrik
    Butzow, Ralf
    Leminen, Arto
    Puistola, Ulla
    Tapanainen, Juha S.
    Heikinheimo, Markku
    Anttonen, Mikko
    Unkila-Kallio, Leila
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (07) : 1661 - 1671
  • [5] Peutz-Jeghers syndrome: Diagnostic and therapeutic approach
    Kopacova, Marcela
    Tacheci, Iija
    Rejchrt, Stanislav
    Bures, Jan
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (43) : 5397 - 5408
  • [6] Kulkarni Nagarekha, 2015, Iran J Pathol, V10, P61
  • [7] The Anti-Mullerian hormone and ovarian cancer
    La Marca, Antonio
    Volpe, Annibale
    [J]. HUMAN REPRODUCTION UPDATE, 2007, 13 (03) : 265 - 273
  • [8] Granulosa cell tumor of the ovary
    Pectasides, D.
    Pectasides, E.
    Psyrri, A.
    [J]. CANCER TREATMENT REVIEWS, 2008, 34 (01) : 1 - 12
  • [9] Staging classification for cancer of the ovary, fallopian tube, and peritoneum
    Prat, Jaime
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2014, 124 (01) : 1 - 5
  • [10] RECURRENT OVARIAN SEX CORD TUMOR WITH ANNULAR TUBULES - TUMOR-MARKER AND CHEMOTHERAPY EXPERIENCE
    PULS, LE
    HAMOUS, J
    MORROW, MS
    SCHNEYER, A
    MACLAUGHLIN, DT
    CASTRACANE, VD
    [J]. GYNECOLOGIC ONCOLOGY, 1994, 54 (03) : 396 - 401